In this in vitro study, we show evidence for a differential expression pattern of Bcl-2 family members in B and T cell subsets of patients with SLE and RA compared to healthy controls, consisting of aberrant expression in the B cell compartment upon activation in SLE. This evidence concerns the gene BCL2 and systemic lupus erythematosus.